FDA: Diabetes drugs to include severe heart risk warnings

08/14/2007 | Washington Post (tiered subscription model), The

GlaxoSmithKline and Takeda Pharmaceutical Co. Ltd. have agreed to include "black-box" warning labels on their diabetes drugs to caution patients about the risk of heart failure caused by the drugs, the FDA announced Tuesday. The new labels, which recommend close monitoring of patients taking Actos and Avandia, are separate from previous reports that link Avandia to heart attacks.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN